Correlation Between Tarsus Pharmaceuticals and Cementos Pacasmayo

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Tarsus Pharmaceuticals and Cementos Pacasmayo at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Tarsus Pharmaceuticals and Cementos Pacasmayo into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Tarsus Pharmaceuticals and Cementos Pacasmayo SAA, you can compare the effects of market volatilities on Tarsus Pharmaceuticals and Cementos Pacasmayo and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Tarsus Pharmaceuticals with a short position of Cementos Pacasmayo. Check out your portfolio center. Please also check ongoing floating volatility patterns of Tarsus Pharmaceuticals and Cementos Pacasmayo.

Diversification Opportunities for Tarsus Pharmaceuticals and Cementos Pacasmayo

0.71
  Correlation Coefficient

Poor diversification

The 3 months correlation between Tarsus and Cementos is 0.71. Overlapping area represents the amount of risk that can be diversified away by holding Tarsus Pharmaceuticals and Cementos Pacasmayo SAA in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cementos Pacasmayo SAA and Tarsus Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Tarsus Pharmaceuticals are associated (or correlated) with Cementos Pacasmayo. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cementos Pacasmayo SAA has no effect on the direction of Tarsus Pharmaceuticals i.e., Tarsus Pharmaceuticals and Cementos Pacasmayo go up and down completely randomly.

Pair Corralation between Tarsus Pharmaceuticals and Cementos Pacasmayo

Given the investment horizon of 90 days Tarsus Pharmaceuticals is expected to generate 2.36 times more return on investment than Cementos Pacasmayo. However, Tarsus Pharmaceuticals is 2.36 times more volatile than Cementos Pacasmayo SAA. It trades about 0.08 of its potential returns per unit of risk. Cementos Pacasmayo SAA is currently generating about 0.03 per unit of risk. If you would invest  1,517  in Tarsus Pharmaceuticals on September 3, 2024 and sell it today you would earn a total of  3,728  from holding Tarsus Pharmaceuticals or generate 245.75% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Tarsus Pharmaceuticals  vs.  Cementos Pacasmayo SAA

 Performance 
       Timeline  
Tarsus Pharmaceuticals 

Risk-Adjusted Performance

26 of 100

 
Weak
 
Strong
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Tarsus Pharmaceuticals are ranked lower than 26 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively unsteady basic indicators, Tarsus Pharmaceuticals unveiled solid returns over the last few months and may actually be approaching a breakup point.
Cementos Pacasmayo SAA 

Risk-Adjusted Performance

2 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Cementos Pacasmayo SAA are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of rather sound basic indicators, Cementos Pacasmayo is not utilizing all of its potentials. The recent stock price tumult, may contribute to shorter-term losses for the shareholders.

Tarsus Pharmaceuticals and Cementos Pacasmayo Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Tarsus Pharmaceuticals and Cementos Pacasmayo

The main advantage of trading using opposite Tarsus Pharmaceuticals and Cementos Pacasmayo positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Tarsus Pharmaceuticals position performs unexpectedly, Cementos Pacasmayo can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cementos Pacasmayo will offset losses from the drop in Cementos Pacasmayo's long position.
The idea behind Tarsus Pharmaceuticals and Cementos Pacasmayo SAA pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.

Other Complementary Tools

Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation